Management of Vertigo
For BPPV, perform the canalith repositioning procedure (Epley maneuver) immediately upon diagnosis—this is the definitive first-line treatment with 80-98% success rates, and vestibular suppressant medications should NOT be routinely prescribed. 1, 2
Diagnostic Algorithm
Step 1: Identify the Type of Vertigo
For suspected BPPV (most common cause):
- Perform the Dix-Hallpike maneuver to diagnose posterior canal BPPV (85-95% of cases): bring patient from upright to supine with head turned 45° to one side and neck extended 20°, looking for torsional upbeating nystagmus 1
- If Dix-Hallpike shows horizontal or no nystagmus but history suggests BPPV, perform the supine roll test for lateral canal BPPV (10-15% of cases) 1
- Do NOT order imaging or vestibular testing unless there are atypical neurological signs (abnormal cranial nerves, severe headache, visual disturbances) 1, 2
Before proceeding with treatment, assess for modifying factors:
- Impaired mobility or balance
- CNS disorders
- Lack of home support
- Increased fall risk (BPPV increases fall risk 12-fold, especially in elderly) 1, 2
Treatment Protocol for BPPV
Posterior Canal BPPV (Most Common)
Perform the Epley maneuver immediately:
- Patient seated upright, head turned 45° toward affected ear 2, 3
- Rapidly move to supine with head hanging 20° below horizontal for 20-30 seconds 2, 3
- Turn head 90° to unaffected side, hold 20-30 seconds 2, 3
- Turn head and body another 90° (face down position), hold 20-30 seconds 2, 3
- Return to sitting position 2, 3
Critical post-procedure instructions:
- Patients can resume normal activities immediately—do NOT recommend postprocedural restrictions (strong evidence shows no benefit and may cause unnecessary complications) 1, 2
Alternative for posterior canal BPPV:
- Semont (Liberatory) maneuver: 94.2% resolution at 6 months 2
Lateral (Horizontal) Canal BPPV
For geotropic variant:
- Barbecue Roll (Lempert) maneuver: roll patient 360° in sequential 90° steps, success rate 50-100% 2, 4
- Gufoni maneuver: patient moves from sitting to side-lying on unaffected side for 30 seconds, then quickly turn head 45-60° toward ground for 1-2 minutes, success rate 93% 2, 4
For apogeotropic variant:
- Modified Gufoni maneuver: patient lies on affected side instead 2
Medication Management
DO NOT routinely prescribe vestibular suppressants (meclizine, antihistamines, benzodiazepines):
- No evidence of effectiveness as definitive treatment for BPPV 1, 2, 3
- Cause significant adverse effects: drowsiness, cognitive deficits, increased fall risk 2, 5
- Interfere with central compensation mechanisms 2
Limited exception:
- May consider ONLY for short-term management (1-3 days) of severe nausea/vomiting in severely symptomatic patients 2, 3
- Meclizine FDA-approved for vertigo associated with vestibular system diseases, but guideline evidence supersedes this for BPPV specifically 5
Follow-Up and Treatment Failures
Reassess within 1 month to confirm symptom resolution 1, 2, 3
If symptoms persist after initial treatment:
- Repeat the diagnostic test (Dix-Hallpike or supine roll) to confirm persistent BPPV 2
- Perform additional repositioning maneuvers—repeat CRP achieves 90-98% success rates 2, 4, 3
- Check for canal conversion (occurs in 6-7% of cases): posterior may convert to lateral or vice versa 1, 2, 3
- Evaluate for multiple canal involvement (rare but possible) 2
- Rule out coexisting vestibular dysfunction if symptoms occur with general head movements or spontaneously 2
- Consider CNS disorders masquerading as BPPV if atypical features present (especially after 2-3 failed properly performed maneuvers): obtain thorough neurological exam and consider MRI of brain/posterior fossa 1, 2
Adjunctive Vestibular Rehabilitation
May offer vestibular rehabilitation therapy (VRT) as adjunct, NOT substitute for CRP:
- Particularly beneficial for patients with residual dizziness, postural instability, or heightened fall risk after successful CRP 2, 4
- Reduces recurrence rates by approximately 50% 2
- Patients treated with CRP plus VRT show significantly improved gait stability compared to CRP alone 2
VRT components:
- Habituation exercises: repeat movements provoking vertigo until symptoms fatigue 4, 6
- Adaptation exercises: head-eye movements with various body postures 4, 6
- Balance training: maintaining balance with reduced support base 4, 6
- Brandt-Daroff exercises: significantly less effective than CRP (24% vs 80.5% success at 1 week) but may be used for patients with contraindications to CRP 2, 4
For patients unable to perform standard maneuvers:
- Severe cervical stenosis or radiculopathy 2
- Severe rheumatoid arthritis or ankylosing spondylitis 2
- Morbid obesity 2
- Limited cervical range of motion 1, 2
Management of Meniere's Disease
If vertigo is due to Meniere's disease (not BPPV):
- Treatment goals: reduce severity/frequency of vertigo attacks, relieve associated symptoms, improve quality of life 4
- Salt restriction and diuretics to prevent flare-ups 7, 8
- Vestibular suppressants (anticholinergics, benzodiazepines) during acute attacks only 7
- Once acute fluctuating symptoms controlled, vestibular rehabilitation therapy demonstrates significant improvement in balance function 9, 10
- Non-ablative procedures preferred for patients with usable hearing 4
Recurrence Management
BPPV has high recurrence rates:
Each recurrence should be treated with repeat CRP, which maintains same high success rates of 90-98% 2
Counsel patients regarding:
- Impact on safety and fall risk 1
- Potential for recurrence 1
- Importance of follow-up 1
- Home safety assessment and activity restrictions if high fall risk 2
Common Pitfalls to Avoid
- Relying on medications instead of repositioning maneuvers—this is the most common error 2, 3
- Failing to reassess patients after initial treatment 2, 3
- Missing canal conversions or multiple canal involvement 2, 3
- Not moving patient quickly enough during maneuvers reduces effectiveness 2
- Ordering unnecessary imaging or vestibular testing in straightforward BPPV cases 1, 2
- Recommending postprocedural restrictions after CRP—strong evidence shows no benefit 1, 2